Document Type : Review Paper

Authors

1 Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq

2 College of Biotechnology, Al-Nahrain University, Baghdad, Iraq.

3 Department of Renewable Energy, College of Energy and Environmental Sciences, Alkarkh University of Science, Baghdad, Iraq.

4 Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, United States of America.

5 Department of Chemistry, College of Science, University of Anbar, Anbar, Iraq.

6 Department of Chemistry, College of Science, Babylon University, Babil, Iraq.

7 Department of Medical Laboratory Sciences, Charmo University, Chamchamal, Kurdistan Region, Iraq.

Abstract

On the 31st of December 2019, China reported several pneumonia-like infections in Wuhan's Huanan Seafood Wholesale Market. Ten days later, a novel coronavirus (2019-nCoV) was announced by the Chinese center for disease control (CCDC). At that time, the genome sequence was publicly made available. The genome sequence analysis of the newly identified virus was found similar to 75-80% of the SARS-CoV clade and more than 88% of bat corona viruses. On January 30th, the World Health Organization (WHO) declared a state of emergency due to the COVID-19 epidemic. In March 2020, the WHO raised a state of emergency and declared that COVID-19 has become a pandemic. Unfortunately, Iraq confirmed the first cases of COVID-19 in February 2020. On April 25th, 46,135 tests were conducted in Iraq with 1763 positive cases. Although Iraq is making great efforts to contain the COVID-19 pandemic stimulating all the available capabilities, such as having a full lockdown and teaching people about the sickness danger, the numbers of cases and deaths started to dramatically increase in June. Now, on the 2nd of July, the infection and death cases were around 54 K and 2.2 K, respectively. Herein, we outline the challenges that the Iraqi health sector is facing to control the spread of COVID-19 with procedures followed so far. This could assist in understanding the severity of the situation and end up with a realistic understanding of it.
 

 

Keywords

Main Subjects

[1] Kah.J. S and McIntosh K., 2005 “History and recent advances in coronavirus discovery.,” Pediatr. Infect. Dis. J., vol. 24, no. 11 Suppl, p. S223–7, discussion S226.
[2] Zhang.D, Wang .W., Li. X., Yang. B., Song.J., Zhao.X, B. Huang, Shi .W, Lu.R., Niu.P.,and Zhan. F., 2020 “A Novel Coronavirus from Patients with Pneumonia in China, 2019,” N. Engl. J. Med., vol. 382, no. 8, pp. 727–733.
[3] Mousavizadeh. L and Ghasemi .S, 2020 “Genotype and phenotype of COVID-19: Their roles in pathogenesis,” J. Microbiol Immunol, pp. 1–23.
[4] Hamming.I, Timens.W, Bulthuis. M. L. C.,  Lely .A. T, Navis .G. J., and Goor.H. van, 2004 “Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis,” J. Pathol. A J. Pathol. Soc. Gt. Britain Irel., vol. 203, no. 2, pp. 631–637.
[5] Wrapp.D , Wang.N. , Corbett. K. S, Goldsmith .J. A, and Ching-Lin Hsieh ,2020, “Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,” Science (80-. )., vol. 367, no. 6483, p. 1260 LP-1263.
[6] Su.S., Wong.G.,.Shi.W, Liu.J.,A. Lai C.K,and Zhou1.J, 2016“Epidemiology, genetic recombination, and pathogenesis of coronaviruses,” Trends Microbiol., vol. 24, no. 6, pp. 490–502.
[7] Cyranoski.D,2020 “Mystery deepens over animal source of coronavirus.,” Nature, vol. 579, no. 7797, pp. 18–19.
[8] Lu.R, Zhao.X, Li.J, Niu.P., Yang.B.,and Wu.H., 2020“Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding,” Lancet, vol. 395, no. 10224, pp. 565–574.
[9] Zhou.P, Yang.X, Wang.X, Hu.B,  Zhang.L, Zhang.W, Si.H, Zhu.Y, Li.B, Huang.C, and Chen.H,2020 “Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin,” Nature.
[10]  Zhou.P, Yang.X,Wang.X, Hu.B, Zhang.L, Zhang.W, Si.H,and Zhu.Y., 2020“A pneumonia outbreak associated with a new coronavirus of probable bat origin,” Nature, vol. 579, no. 7798, pp. 270–273.
[11] Du.L, He.Y, Zhou.Y, Liu.S, Zheng.B.J, and Jiang S., 2009“The spike protein of SARS-CoV - A target for vaccine and therapeutic development,” Nat. Rev. Microbiol., vol. 7, no. 3, pp. 226–236.
[12] Yadav D. K., Shah S. P., Shah P. K., and Yadav A. K., “Does use of disposable latex gloves by general population protect them from getting infected with SARS-CoV-2 during COVID-19 pandemic.”
[13] Van Doremalen N., Morris D, Holbrook.M, Gamble .A., Williamson B., Tamin A., Lloyd-Smith J., and Wit E.,2020 “Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1,” N. Engl. J. Med., vol. 382, no. 16, pp. 1564–1567.
[14] Hadi A., . Kadhom M, Yousif E., and Hairunisa N.,2020, In COVID-19 time, how to protect myself and others? a review, Jurnal biomedika dan kesehatan.
[15] Lauer S., Grantz K., Bi Q., Jones F., Zheng Q., Meredith.H, Azman.A, Reich.N,and Lessler J.,2020 “The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application,” Ann. Intern. Med.
[16] Jaaffar A. I., Al-Mahmood S., Maeh R. K., and Alyasiry M.,2019, “Microbiological profile with antibiotic resistance pattern in patients of pneumonia in Iraq.,” Drug Invent. Today, vol. 11, no. 11.
[17] "Covid-19 situation update in Iraqi   Kurdistan". gov.krd/coronavirus-en.
[18]   Data from the Iraqi Association for Medical research and Studies (IAMRS), accessed on the 30th April 2020 via https://www.iamrs.edu.iq/iraqi-daily-covid-19-report-28_4_2020/
[19] Deguenon.E, Victorien D, Jean-pierre G, Mathieu H, Phénix A, Lamine Baba-moussa, and Jacques D. 2020, “Knowledge Status and Potential Impact of Socio-Economic Factors on the Spreading of COVID-19 in West African Countries,” 1–5. https://doi.org/10.22401/ANJS.00.3.01.
 
[20] Hadi A., Kadhom M., Hairunisa N., Yousif E., and Mohammed S.,2020 “A Review on COVID-19: Origin, Spread, Symptoms, Treatment, and Prevention” Biointerface Res. Appl. Vol. 10, Issue 6, 7234 – 7242.
[21] Alsayed.R., Kadhom M., Yousif E.,and Sabir D., 2020“An Epidemiological Characteristic of the COVID-19 Among Children” Lett. Appl. NanoBioScience. Vol. 9, Issue 3, 1156 – 1164.
 [22] Wedad Al-Dahhan, Al-Mashhadani M. H., Raheem.R., and Yousif E.,2020 “Iraq Faces the COVID-19 with Limited Health Capabilities and Major Medical Challenges” News and Views, 5 (3), 1271-1274.
[23] Al-mashhadani.M., Alsayed.R., Hussain.Z., Salih N, and Yousif.E.,2020 “An Overview of Possible Therapeutic Approaches Against Novel Coronavirus Disease 2019 Pandemic” Al-Nahrain Journal of Science, Special Issue: COVID-19, 6-11.